Efficacy and safety of ceftazidime/avibactam in patients with infections caused by β-lactamase-producing Gram-negative pathogens: a pooled analysis from the Phase 3 clinical trial programme.
Antoní TorresMichele WibleMargaret TawadrousPaurus IraniGregory G StoneAlvaro QuintanaDmitri DebabovMargaret BurroughsPatricia A BradfordMarin KollefPublished in: The Journal of antimicrobial chemotherapy (2023)
NCT01499290; NCT01726023; NCT01644643; NCT01595438/NCT01599806; NCT01808092.